Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 18, Issue 5-6, Pages 211-247
http://dx.doi.org/10.1155/2002/879647

Assessment of Cancer-Associated Biomarkers by Positron Emission Tomography: Advances and Challenges

T. Lee Collier,1 Roger Lecomte,3 Timothy J. McCarthy,5 Steve Meikle,6 Thomas J. Ruth,4 Francesco Scopinaro,7 Alberto Signore,7 Henry Van Brocklin,8 Christophe Van de Wiele,9 and Rikki N. Waterhouse2

1PETNET Pharmaceuticals, North Wales, PA, USA
2Department of Psychiatry, Columbia University, New York, NY, USA
3Department of Nuclear Medicine and Radiobiology, Université de Sherbrooke, Québec, Canada
4UBC/TRIUMF PET Program, University of British Columbia, Canada
5Pharmacia, Peapack, NJ, USA
6Department of PET and Nuclear Medicine, Royal Prince Alfred Hospital, Sydney, Australia
7Department of Nuclear Medicine, University "La Sapienza", Roma, Italy
8Department of Nuclear Medicine and Functional Imaging, Lawrence Berkeley National Laboratory, Berkeley CA, USA
9Division of Nuclear Medicine, University Hospital Ghent, Ghent, Belgium

Received 17 November 2003; Accepted 17 November 2003

Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

T. Lee Collier, Roger Lecomte, Timothy J. McCarthy, et al., “Assessment of Cancer-Associated Biomarkers by Positron Emission Tomography: Advances and Challenges,” Disease Markers, vol. 18, no. 5-6, pp. 211-247, 2002. https://doi.org/10.1155/2002/879647.